SlideShare a Scribd company logo
1 of 31
2010-2011
2nd Term 2nd Semester
Aerobic Gram-positive spore forming bacilli:
     Bacillus anthracis and other Bacillus species
 Bacillus anthracis
     Aerobic , Gram positive, Spore forming bacilli
     Causes anthracis, a zoonotic disease transmitted from animals to
      humans

 Definition of Cases in anthracis diagnostics
Confirmed Case:
    Clinically compatible confirmed by isolation of B. anthracis
     based on two laboratory tests
Suspected Case:
    Clinically compatible with one supportive lab test
Three forms of anthracis disease

 Cutaneous anthracis
    Usually forms black necrotic ulcer (eschar)


 Inhalational anthracis
    Hypoxia and dyspnea, often with radiographic evidence of mediastinal
     widening. Most serious

 Gastrointestinal anthracis
 Abdominal distress, usually accompanied by bloody vomiting and diarrhea,
  followed by fever, septicemia (poorly cooked meat.
Cutaneous anthracis
Vesicle development Day 2
                                      Day 4



                                          Day2    Day 6




                                                   Day 10

   Mediastinal Widening and Pleural       Eschar formations
Effusion on Chest X-Ray in Inhalational
               Anthrax
B. anthracis:
      Presumptive Identification

        specimen (blood, CSF, etc.)

  Gram Positive         Isolate on SBA
Capsule production
                     Madusa Head Colony
                        NonHemolytic
                         NonMotile
                           Spores   Gram stain
                                    Malachite green
B. anthracis:
     Confirmatory Identification
                      Isolate

                   Capsule                       DFA
Phage
 lysis                                      Capsule antigen
           Horse         Bicarbonate
                                               Cell wall
           blood            media
         (M’Fadyean     (M’Fadyean stain
            Stain)       India ink stain)
Recommended Post-exposure Prophylaxis to
      Prevent Inhalational Anthrax
                                 Initial Therapy        Duration
Adults                            Ciprofloxacin          60 days
                                500 mg PO BID
                                        OR
                                   Doxycycline
                                100 mg PO BID
Children                         Ciprofloxacin*          60 days
                          10–15 mg/kg PO Q 12 hrs      Change to
                                        OR             amoxicillin
                                  Doxycycline:       if susceptible
                      >8 yrs and >45 kg: 100 mg PO BID
                      >8 yrs and <45 kg: 2.2 mg/kg PO BID
                           <8 yrs: 2.2 mg/kg PO BID
           *Ciprofloxacin not to exceed 1 gram daily in children
              Patient information sheets at www.bt.cdc.gov
Cutaneous Anthrax Treatment Protocol
Category                                 Initial Therapy (Oral)                      Duration
Adults                                        Ciprofloxacin                          60 daysw
                                               500 mg BID
                                                   OR
                                               Doxycycline
                                               100 mg BID

Children                                  Ciprofloxacin**          60 daysw
                                      10–15 mg/kg Q 12 hrs
                                                 OR
                                           Doxycycline:
                                  >8 yrs and >45 kg: 100 mg BID
                                  >8 yrs and <45 kg: 2.2 mg/kg BID
                                       <8 yrs: 2.2 mg/kg BID
 **Ciprofloxacin not to exceed 1 gram daily in children.   w60-day duration is to prevent inhalational anthrax.

                                Patient information sheets at www.bt.cdc.gov
                                  *Source MMWR 2001;50:909–19
Inhalational Anthrax Treatment Protocol*
Category                 Initial therapy (intravenous)                   Duration
Children                        Ciprofloxacin                       Switch to oral
                            10–15 mg/kg Q 12 hrs                    therapy when
                                     OR                                clinically
                                 Doxycycline                         appropriate:
                             >8 yrs and >45 kg:                     Ciprofloxacin
                              100 mg Q 12 hrs                   10–15 mg/kg Q 12 hrs
                             >8 yrs and <45 kg:                           OR
                             2.2 mg/kg Q 12 hrs                      Doxycycline
                                    <8 yrs:                       >8 yrs and >45 kg:
                             2.2 mg/kg Q 12 hrs                      100 mg BID
                                     AND                          >8 yrs and <45 kg:
                            One or two additional                   2.2 mg/kg BID
                                antimicrobials                  <8 yrs: 2.2 mg/kg BID
**Ciprofloxacin not to exceed 1 gram daily   wContinue   for 60 days (IV and po combined)
                      Patient information sheets at www.bt.cdc.gov
                        *Source MMWR 2001;50:909–19
Immune Protection Against Anthrax
 Live cellular vaccines
   "Sterne" type live spore
   Former USSR STI live spore
   "Pasteur" type
 Sterile, acellular vaccines
   US "anthrax vaccine adsorbed" (AVA)—not licensed
    for use in civilian populations
   UK "anthrax vaccine precipitated" (AVP)
Other Bacillus species: B. cereus, B. subtlis


 Large, motile, saprophytic bacillus with Heat resistant spores
 Lab diagnosis – Demonstation of large number of bacilli in food
 Food poisoning (meat, poultry, and soups)
   Diarrheal syndrome (Heat labile enterotoxin)
   Emetic form (Pre formed heat and acid stable toxin) ( with fried rice)


Bacillus subtilis
   Common laboratory contaminant
Anaerobic Gram-positive spore forming bacilli:
    1. Closteridium perfringens: Gas gangrene and Food Poisoning
 Gram-positive, anaerobic, nonmotile, capsulated, spore-forming
  rods
      Clostridium (Greek Kloster meaning spindle)
      Spores if formed are oval, sub-terminal and non bulging
 Causes Gasgangrene: How?
     Saccharolytics strongly ferment carbohydroates and produce acid and gas
     Proteolytic digests proteins, blackening soul smell due to sulfur
     compounds, in addition to toxins
 food poisoning: How? (enterotoxin heat labile toxin produced in colon, -toxin
  responsible for necrotizing enterocolitis)



     toxin
          Lyses of RBCs, platelets, leucocytes and endothelial cells that increased
           vascular permeability leading to Hepatic toxicity and myocardial
           dysfunction
clostridium perfringenes infection




 Gas gangrene        necrotizing enterocolitis:
                     Food poisoning in
                     chicken
Diagnostics: Litmus Milk Reaction showing
          Saccharolytic and proteolytic properties of Cl. perfringnes
 1- Acidic Reaction
                  Fermented to        Litmus Indicator
   Lactose                     Acid               Pink Color
   in Milk

 2- Basic Reaction
             Digestion                Litmus Indicator
Casein                   Alkaline amines          Blue Color
in Milk




 2- Stormy fermentation
 Too much acid and gas
Anaerobic Media
 Thioglycollate broth
         Sodium thioglycollate (Reducing agent, obsorbs O2)
         Rezazurin (redox indicator, can be added)
         Soft-liquid Agar

 Robertson's Cooked Meat Medium
   Meat particles of heart muscles contain
   hematin & glutathione reducing agent




   Anaerobic Jar
Plastic jar with a tightly fitted lid. Hydrogen is
introduced from commercially available hydrogen generator
 envelop.
10 ml of water is added to envelop immediately before placing
 it in the jar. Hydrogen and carbon dioxide will release and react
 with oxygen in the presence of catalyst to form water droplet
Treatment of illness
 No specific treatment. Supportive care include:
    Restore intravenous fluid, monitor urine, and control fever and pain
    Consider hyperbaric oxygen therapy. Why?
        Clostridia lack superoxide dismutase, making them incapable of surviving in the
         oxygen-rich environment created within a hyperbaric chamber. This inhibits
         clostridial growth


 Antibiotics as high doses of penicillin, Clindamycin may help



 The hallmarks of this disease are rapid onset of myonecrosis with
  muscle swelling, severe pain, gas production, and sepsis, so
  controlling these is priority
Clostridium tetani: Tetanus (meaning Contract in Greek)
 Gram-positive, anaerobic, motile, drum-stick spore-
  forming rod commonly found: Soil, GI tracts of animals,
  environments.
 Therefore, spores enter through animal bites, accidental
  cuts, punctures, wounds, burns, umbilical stumps,
  frostbite, and crushed body parts.
 Common disease symptoms:
   Tetanospasmin – Heat labile neurotoxin blocks release of
    neurotransmitter (glycine)for muscular contraction; muscles
    contract uncontrollably. Tetanolysin, heat stable hemolysin
   Death most often due to paralysis of respiratory muscles
   Estimated human lethal dose(2.5 ng/kg).
 Diagnosis is mostly by physical, medical, clinical symptoms
 and immunization history
Types of Tenaus
 Generalized Tetanus: spreads to muscles of the face, neck and truck in usually a
  descending pattern.




 local tetanus: toxin reaches motor nerve endings, neurones of the peripheral
  nerve to the anterior horn cells, and cause local tetanus
 Ascending tetanus: toxins spreads upwards

 Neonatal tetanus: …generalized baby spasm.
Usually if the mother has not been immunized
.
Cephalic Tetanus: Rare; from otitis media
Diagnosis, Prophylaxis, and treatment options

 Diagnosis: Gram stain
    Spore are diagnostic, bigger than bacteria, and   bulge as drum-stick

    Diagnosis is mostly by physical, medical, clinical symptoms and immunization
       history

 Prophylaxis, and treatment options
    Antitoxin therapy with human tetanus immune globulin; inactivates circulating
       toxin
      Control infection with penicillin or tetracycline; and muscle relaxants
      Supportive therapy (ventilator)
      Vaccine available; booster needed every 10 years
      Part of regular vaccination schedule:
          Triple Vaccine DPT (Diphtheria, Pertussis, Tetanus)
          Nowadays: DTaP-Polio-Hib
Principles of vaccination
“Immunological Memory”
Recent schedule for Vaccination of Newborns in Saudi Arabia. Starting January 2008.

                      Age at visit                           Vaccines
                                                  •    BCG
           At birth
                                                  •    HepB
                                                  •    IPV
           2 - Months
                                                  •    [ DTP, HepB , Hib ]
                                                  •   OPV
           4 - Months
                                                  •   [ DTP, HepB, Hib ]
                                                  •   OPV,
           6 - Months
                                                  •   [ DTP, HepB , Hib ]
                                                  •   Measles ( mono )
           9 - Months
                                                  • OPV ,MMR
          12 - Months
                                                  • Varicella
                                                  • OPV
          18 - Months
                                                  • DTP, Hib
                                                  • Hepatitis (A)
          24 - Months
                                                  • Hepatitis (A)
          4 - 6 Years
                                                  • OPV,DTP,MMR, Varicella.
Clostridium Botulism : Case Presentation
 An afebrile and alert patient reported at a local hospital with
 blurred and double vision, muscle weakness, drooping eyelids,
 slurred speech, and apparent difficulty swallowing was.
 Immediate treatment was suggested including:
 Antitoxin administration
 Supportive Care
     mechanical ventilation
     body positioning
     Induced vomiting
Clostridium botulism (Botulus = sausage in Latin)
 Gram positive, anaerobic, Mobile, subterminal spore forming
  bacilli




 Three botulism Types:
    Foodborne botulism
      (incubation period ) 6 hours-8 days ( Preformed toxin ingested from contaminated
       food) home canned Food, honey, crushed wounds, drug injection
    Infant botulism, foods such as honey
    Wound botulism (incubation period) > 4 days
Mechanism of Botulism toxin
 Produce seven botulism toxins A –G
    One of the exteremely potent toxins known 1 aerosolized gram
     could potentially kill 1 million people
    Prevents release of neurotransmitter acetylecholine



 Toxin enters blood stream and binds to cholinergic nerves blocks
  release of acetylcholine and prevents muscle contractions
  resulting in descending paralysis starting with cranial nerves to
  downward to respiratory obstruction
 Toxin destroyed by boiling, but spores need higher temp
Botulism Laboratory Procedures
 Microscopic/culture not reliable, toxin detection and assay
 Toxin neutralization in mouse
    serum, stool, gastric aspirate, suspect foods
 Isolation of C. botulinum
    in food/faeces, wound, tissue, or gastric
    Strict anaerobe, extremely sensitive to oxygen
 Clinical signs
 Electromyography also diagnostic
Prophylaxis and Treatment
 Immediate Intensive care once suspected clinically…
    Ventilator for respiratory failure
    trivalent antitoxin, administer gastric lavage,
    metronidazole or penicillin eliminates veg form from GI,
 Botulinum antitoxin
    Derived from equine source
    Trivalent and bivalent antitoxins available through the CDC
    Licensed trivalent antitoxin neutralizes type A, B, and E and
     botulism toxins
 Botulism immune globulin
    Infant cases of types A and G
Therapeutic uses of Botulism Toxin
 Involuntary muscles, such as uncontroled eye movements
 Cosmetic use


Caution required:
 70 yrs old underwent
botulinum toxin injection
to the left inferior rectus muscle,
Resulted in loss of the muscle
Clostridium difficile-Associated Diarrhea
                    (CDAD)
 A group of long term facility patients who were under
  extended antibiotic treatment all suddenly developed
  watery diarrhea 10 to 15 times a day, dehydration, fever, loss
  of appetite, nausea, and abdominal pain/tenderness, and
  signs of pseudomembranous colitis (damaged
  tissues,mucus in feces). Upon a quick Gram staining, gram
  positive spore forming bacilli dominated in samples from
  all patients.

 Reason: Antibiotic overuse
    Long term treatment with broad-spectrum antibiotics kills
     the other bacteria, allowing C. difficile to overgrow, produce
     enterotoxins that damage intestines, cause diarrhea and
     colitis
Clostridium difficile



 Gram positive, anaerobic spore forming, bacilli
 Normal resident of colon
 In the industrialized world, it is one of the most common
  diarrheal infections in hospitals and long-term care facilities


 Causes antibiotic-associated colitis
    relatively non-invasive; treatment with broad-spectrum antibiotics kills
     the other bacteria, allowing C. difficile to overgrow
 Produces enterotoxins that damage intestines
 Major cause of diarrhea in hospitals
 Increasingly more common in community acquired diarrhea
Treatment and prevention

 Mild uncomplicated cases respond to fluid and
  electrolyte replacement and withdrawal of
  antimicrobials.
 Severe infections treated with oral vancomycin or
  metronidazole and replacement cultures
 Increased precautions to prevent spread

More Related Content

Viewers also liked

1 spore-forming gram-positive bacilli 2014
1   spore-forming gram-positive bacilli 20141   spore-forming gram-positive bacilli 2014
1 spore-forming gram-positive bacilli 2014May Alwakil
 
Veterinary important Clostridium species
Veterinary important Clostridium speciesVeterinary important Clostridium species
Veterinary important Clostridium speciesABDULLAH ALHATAMI
 
Non spore forming anaerobic bacteria
Non spore forming anaerobic bacteriaNon spore forming anaerobic bacteria
Non spore forming anaerobic bacteriaBruno Mmassy
 
Digestive System - Physiology
Digestive System - PhysiologyDigestive System - Physiology
Digestive System - PhysiologyCU Dentistry 2019
 
ClOSTRIDIUM perfringens
ClOSTRIDIUM perfringens ClOSTRIDIUM perfringens
ClOSTRIDIUM perfringens Imtiyazz Wanii
 

Viewers also liked (6)

1 spore-forming gram-positive bacilli 2014
1   spore-forming gram-positive bacilli 20141   spore-forming gram-positive bacilli 2014
1 spore-forming gram-positive bacilli 2014
 
Veterinary important Clostridium species
Veterinary important Clostridium speciesVeterinary important Clostridium species
Veterinary important Clostridium species
 
Non spore forming anaerobic bacteria
Non spore forming anaerobic bacteriaNon spore forming anaerobic bacteria
Non spore forming anaerobic bacteria
 
Digestive System - Physiology
Digestive System - PhysiologyDigestive System - Physiology
Digestive System - Physiology
 
ClOSTRIDIUM perfringens
ClOSTRIDIUM perfringens ClOSTRIDIUM perfringens
ClOSTRIDIUM perfringens
 
Tetanus
TetanusTetanus
Tetanus
 

Similar to 2nd term lectures,_bacilli[1]

RINO DRUGS PPT.pptx
RINO DRUGS PPT.pptxRINO DRUGS PPT.pptx
RINO DRUGS PPT.pptxHemaBalan5
 
NNF ready reckoner.pdf
NNF ready reckoner.pdfNNF ready reckoner.pdf
NNF ready reckoner.pdfKickKick6
 
Malaria by affan ali(036)
Malaria by affan ali(036)Malaria by affan ali(036)
Malaria by affan ali(036)AFFAN ALI
 
Nephrotic syndrome treatment update by Dr. G.Malini
Nephrotic syndrome treatment update by Dr. G.MaliniNephrotic syndrome treatment update by Dr. G.Malini
Nephrotic syndrome treatment update by Dr. G.MaliniRaghavendra Babu
 
Pediatric COVID guidelines update.pptx
Pediatric COVID guidelines update.pptxPediatric COVID guidelines update.pptx
Pediatric COVID guidelines update.pptxmaihunny113
 
Ihc poultry treatment catalgoue
Ihc   poultry treatment catalgoueIhc   poultry treatment catalgoue
Ihc poultry treatment catalgouePvs Ihc
 
Polymyxins revisited
Polymyxins revisitedPolymyxins revisited
Polymyxins revisitedPathKind Labs
 
Drug dosage and antibiotics in pediatric dentistry
Drug dosage and antibiotics in pediatric dentistryDrug dosage and antibiotics in pediatric dentistry
Drug dosage and antibiotics in pediatric dentistryDrKhyaati
 
Pharmacological advances in canine and feline reproduction
Pharmacological advances in canine and feline reproductionPharmacological advances in canine and feline reproduction
Pharmacological advances in canine and feline reproductionDR. Md. Moktadir Billah Reza
 
Pharmacological advances in canine and feline reproduction
Pharmacological advances in canine and feline reproductionPharmacological advances in canine and feline reproduction
Pharmacological advances in canine and feline reproductionDR. Md. Moktadir Billah Reza
 
renal dose pediatrics according to their GFR
renal dose pediatrics according to their GFRrenal dose pediatrics according to their GFR
renal dose pediatrics according to their GFRNada Abuzaid
 
Amoxicillin drug profile: By RxVichuZ! :)
Amoxicillin drug profile: By RxVichuZ! :)Amoxicillin drug profile: By RxVichuZ! :)
Amoxicillin drug profile: By RxVichuZ! :)RxVichuZ
 
Probiotics in Health & Disease
Probiotics in Health & Disease Probiotics in Health & Disease
Probiotics in Health & Disease Mahesh Hiranandani
 

Similar to 2nd term lectures,_bacilli[1] (20)

RINO DRUGS PPT.pptx
RINO DRUGS PPT.pptxRINO DRUGS PPT.pptx
RINO DRUGS PPT.pptx
 
NNF ready reckoner.pdf
NNF ready reckoner.pdfNNF ready reckoner.pdf
NNF ready reckoner.pdf
 
DOH National Antibiotic Guidelines 2016 (UTI)
DOH National Antibiotic Guidelines 2016 (UTI)DOH National Antibiotic Guidelines 2016 (UTI)
DOH National Antibiotic Guidelines 2016 (UTI)
 
Malaria by affan ali(036)
Malaria by affan ali(036)Malaria by affan ali(036)
Malaria by affan ali(036)
 
PediRefCard.pdf
PediRefCard.pdfPediRefCard.pdf
PediRefCard.pdf
 
Nephrotic syndrome treatment update by Dr. G.Malini
Nephrotic syndrome treatment update by Dr. G.MaliniNephrotic syndrome treatment update by Dr. G.Malini
Nephrotic syndrome treatment update by Dr. G.Malini
 
Pediatric COVID guidelines update.pptx
Pediatric COVID guidelines update.pptxPediatric COVID guidelines update.pptx
Pediatric COVID guidelines update.pptx
 
Ihc poultry treatment catalgoue
Ihc   poultry treatment catalgoueIhc   poultry treatment catalgoue
Ihc poultry treatment catalgoue
 
Polymyxins revisted
Polymyxins revistedPolymyxins revisted
Polymyxins revisted
 
Polymyxins revisited
Polymyxins revisitedPolymyxins revisited
Polymyxins revisited
 
Drug dosage and antibiotics in pediatric dentistry
Drug dosage and antibiotics in pediatric dentistryDrug dosage and antibiotics in pediatric dentistry
Drug dosage and antibiotics in pediatric dentistry
 
Pharmacological advances in canine and feline reproduction
Pharmacological advances in canine and feline reproductionPharmacological advances in canine and feline reproduction
Pharmacological advances in canine and feline reproduction
 
Pharmacological advances in canine and feline reproduction
Pharmacological advances in canine and feline reproductionPharmacological advances in canine and feline reproduction
Pharmacological advances in canine and feline reproduction
 
renal dose pediatrics according to their GFR
renal dose pediatrics according to their GFRrenal dose pediatrics according to their GFR
renal dose pediatrics according to their GFR
 
Amoxicillin drug profile: By RxVichuZ! :)
Amoxicillin drug profile: By RxVichuZ! :)Amoxicillin drug profile: By RxVichuZ! :)
Amoxicillin drug profile: By RxVichuZ! :)
 
Ped medhandbook
Ped medhandbookPed medhandbook
Ped medhandbook
 
Ped medhandbook
Ped medhandbookPed medhandbook
Ped medhandbook
 
Diarrhoea
DiarrhoeaDiarrhoea
Diarrhoea
 
Probiotics in Health & Disease
Probiotics in Health & Disease Probiotics in Health & Disease
Probiotics in Health & Disease
 
What's new in c. diff
What's new in c. diffWhat's new in c. diff
What's new in c. diff
 

2nd term lectures,_bacilli[1]

  • 2. Aerobic Gram-positive spore forming bacilli: Bacillus anthracis and other Bacillus species  Bacillus anthracis  Aerobic , Gram positive, Spore forming bacilli  Causes anthracis, a zoonotic disease transmitted from animals to humans  Definition of Cases in anthracis diagnostics Confirmed Case:  Clinically compatible confirmed by isolation of B. anthracis based on two laboratory tests Suspected Case:  Clinically compatible with one supportive lab test
  • 3. Three forms of anthracis disease  Cutaneous anthracis  Usually forms black necrotic ulcer (eschar)  Inhalational anthracis  Hypoxia and dyspnea, often with radiographic evidence of mediastinal widening. Most serious  Gastrointestinal anthracis  Abdominal distress, usually accompanied by bloody vomiting and diarrhea, followed by fever, septicemia (poorly cooked meat.
  • 4. Cutaneous anthracis Vesicle development Day 2 Day 4 Day2 Day 6 Day 10 Mediastinal Widening and Pleural Eschar formations Effusion on Chest X-Ray in Inhalational Anthrax
  • 5. B. anthracis: Presumptive Identification specimen (blood, CSF, etc.) Gram Positive Isolate on SBA Capsule production Madusa Head Colony NonHemolytic NonMotile Spores Gram stain Malachite green
  • 6. B. anthracis: Confirmatory Identification Isolate Capsule DFA Phage lysis Capsule antigen Horse Bicarbonate Cell wall blood media (M’Fadyean (M’Fadyean stain Stain) India ink stain)
  • 7. Recommended Post-exposure Prophylaxis to Prevent Inhalational Anthrax Initial Therapy Duration Adults Ciprofloxacin 60 days 500 mg PO BID OR Doxycycline 100 mg PO BID Children Ciprofloxacin* 60 days 10–15 mg/kg PO Q 12 hrs Change to OR amoxicillin Doxycycline: if susceptible >8 yrs and >45 kg: 100 mg PO BID >8 yrs and <45 kg: 2.2 mg/kg PO BID <8 yrs: 2.2 mg/kg PO BID *Ciprofloxacin not to exceed 1 gram daily in children Patient information sheets at www.bt.cdc.gov
  • 8. Cutaneous Anthrax Treatment Protocol Category Initial Therapy (Oral) Duration Adults Ciprofloxacin 60 daysw 500 mg BID OR Doxycycline 100 mg BID Children Ciprofloxacin** 60 daysw 10–15 mg/kg Q 12 hrs OR Doxycycline: >8 yrs and >45 kg: 100 mg BID >8 yrs and <45 kg: 2.2 mg/kg BID <8 yrs: 2.2 mg/kg BID **Ciprofloxacin not to exceed 1 gram daily in children. w60-day duration is to prevent inhalational anthrax. Patient information sheets at www.bt.cdc.gov *Source MMWR 2001;50:909–19
  • 9. Inhalational Anthrax Treatment Protocol* Category Initial therapy (intravenous) Duration Children Ciprofloxacin Switch to oral 10–15 mg/kg Q 12 hrs therapy when OR clinically Doxycycline appropriate: >8 yrs and >45 kg: Ciprofloxacin 100 mg Q 12 hrs 10–15 mg/kg Q 12 hrs >8 yrs and <45 kg: OR 2.2 mg/kg Q 12 hrs Doxycycline <8 yrs: >8 yrs and >45 kg: 2.2 mg/kg Q 12 hrs 100 mg BID AND >8 yrs and <45 kg: One or two additional 2.2 mg/kg BID antimicrobials <8 yrs: 2.2 mg/kg BID **Ciprofloxacin not to exceed 1 gram daily wContinue for 60 days (IV and po combined) Patient information sheets at www.bt.cdc.gov *Source MMWR 2001;50:909–19
  • 10. Immune Protection Against Anthrax  Live cellular vaccines  "Sterne" type live spore  Former USSR STI live spore  "Pasteur" type  Sterile, acellular vaccines  US "anthrax vaccine adsorbed" (AVA)—not licensed for use in civilian populations  UK "anthrax vaccine precipitated" (AVP)
  • 11. Other Bacillus species: B. cereus, B. subtlis  Large, motile, saprophytic bacillus with Heat resistant spores  Lab diagnosis – Demonstation of large number of bacilli in food  Food poisoning (meat, poultry, and soups)  Diarrheal syndrome (Heat labile enterotoxin)  Emetic form (Pre formed heat and acid stable toxin) ( with fried rice) Bacillus subtilis Common laboratory contaminant
  • 12. Anaerobic Gram-positive spore forming bacilli: 1. Closteridium perfringens: Gas gangrene and Food Poisoning  Gram-positive, anaerobic, nonmotile, capsulated, spore-forming rods  Clostridium (Greek Kloster meaning spindle)  Spores if formed are oval, sub-terminal and non bulging  Causes Gasgangrene: How?  Saccharolytics strongly ferment carbohydroates and produce acid and gas  Proteolytic digests proteins, blackening soul smell due to sulfur compounds, in addition to toxins  food poisoning: How? (enterotoxin heat labile toxin produced in colon, -toxin responsible for necrotizing enterocolitis)  toxin  Lyses of RBCs, platelets, leucocytes and endothelial cells that increased vascular permeability leading to Hepatic toxicity and myocardial dysfunction
  • 13. clostridium perfringenes infection Gas gangrene necrotizing enterocolitis: Food poisoning in chicken
  • 14. Diagnostics: Litmus Milk Reaction showing Saccharolytic and proteolytic properties of Cl. perfringnes 1- Acidic Reaction Fermented to Litmus Indicator Lactose Acid Pink Color in Milk 2- Basic Reaction Digestion Litmus Indicator Casein Alkaline amines Blue Color in Milk 2- Stormy fermentation Too much acid and gas
  • 15. Anaerobic Media  Thioglycollate broth  Sodium thioglycollate (Reducing agent, obsorbs O2)  Rezazurin (redox indicator, can be added)  Soft-liquid Agar  Robertson's Cooked Meat Medium  Meat particles of heart muscles contain  hematin & glutathione reducing agent  Anaerobic Jar Plastic jar with a tightly fitted lid. Hydrogen is introduced from commercially available hydrogen generator envelop. 10 ml of water is added to envelop immediately before placing it in the jar. Hydrogen and carbon dioxide will release and react with oxygen in the presence of catalyst to form water droplet
  • 16. Treatment of illness  No specific treatment. Supportive care include:  Restore intravenous fluid, monitor urine, and control fever and pain  Consider hyperbaric oxygen therapy. Why?  Clostridia lack superoxide dismutase, making them incapable of surviving in the oxygen-rich environment created within a hyperbaric chamber. This inhibits clostridial growth  Antibiotics as high doses of penicillin, Clindamycin may help  The hallmarks of this disease are rapid onset of myonecrosis with muscle swelling, severe pain, gas production, and sepsis, so controlling these is priority
  • 17. Clostridium tetani: Tetanus (meaning Contract in Greek)  Gram-positive, anaerobic, motile, drum-stick spore- forming rod commonly found: Soil, GI tracts of animals, environments.  Therefore, spores enter through animal bites, accidental cuts, punctures, wounds, burns, umbilical stumps, frostbite, and crushed body parts.  Common disease symptoms:  Tetanospasmin – Heat labile neurotoxin blocks release of neurotransmitter (glycine)for muscular contraction; muscles contract uncontrollably. Tetanolysin, heat stable hemolysin  Death most often due to paralysis of respiratory muscles  Estimated human lethal dose(2.5 ng/kg).  Diagnosis is mostly by physical, medical, clinical symptoms and immunization history
  • 18. Types of Tenaus  Generalized Tetanus: spreads to muscles of the face, neck and truck in usually a descending pattern.  local tetanus: toxin reaches motor nerve endings, neurones of the peripheral nerve to the anterior horn cells, and cause local tetanus  Ascending tetanus: toxins spreads upwards  Neonatal tetanus: …generalized baby spasm. Usually if the mother has not been immunized . Cephalic Tetanus: Rare; from otitis media
  • 19.
  • 20. Diagnosis, Prophylaxis, and treatment options  Diagnosis: Gram stain  Spore are diagnostic, bigger than bacteria, and bulge as drum-stick  Diagnosis is mostly by physical, medical, clinical symptoms and immunization history  Prophylaxis, and treatment options  Antitoxin therapy with human tetanus immune globulin; inactivates circulating toxin  Control infection with penicillin or tetracycline; and muscle relaxants  Supportive therapy (ventilator)  Vaccine available; booster needed every 10 years  Part of regular vaccination schedule:  Triple Vaccine DPT (Diphtheria, Pertussis, Tetanus)  Nowadays: DTaP-Polio-Hib
  • 22. Recent schedule for Vaccination of Newborns in Saudi Arabia. Starting January 2008. Age at visit Vaccines • BCG At birth • HepB • IPV 2 - Months • [ DTP, HepB , Hib ] • OPV 4 - Months • [ DTP, HepB, Hib ] • OPV, 6 - Months • [ DTP, HepB , Hib ] • Measles ( mono ) 9 - Months • OPV ,MMR 12 - Months • Varicella • OPV 18 - Months • DTP, Hib • Hepatitis (A) 24 - Months • Hepatitis (A) 4 - 6 Years • OPV,DTP,MMR, Varicella.
  • 23. Clostridium Botulism : Case Presentation  An afebrile and alert patient reported at a local hospital with blurred and double vision, muscle weakness, drooping eyelids, slurred speech, and apparent difficulty swallowing was. Immediate treatment was suggested including:  Antitoxin administration  Supportive Care  mechanical ventilation  body positioning  Induced vomiting
  • 24. Clostridium botulism (Botulus = sausage in Latin)  Gram positive, anaerobic, Mobile, subterminal spore forming bacilli  Three botulism Types:  Foodborne botulism  (incubation period ) 6 hours-8 days ( Preformed toxin ingested from contaminated food) home canned Food, honey, crushed wounds, drug injection  Infant botulism, foods such as honey  Wound botulism (incubation period) > 4 days
  • 25. Mechanism of Botulism toxin  Produce seven botulism toxins A –G  One of the exteremely potent toxins known 1 aerosolized gram could potentially kill 1 million people  Prevents release of neurotransmitter acetylecholine  Toxin enters blood stream and binds to cholinergic nerves blocks release of acetylcholine and prevents muscle contractions resulting in descending paralysis starting with cranial nerves to downward to respiratory obstruction  Toxin destroyed by boiling, but spores need higher temp
  • 26. Botulism Laboratory Procedures  Microscopic/culture not reliable, toxin detection and assay  Toxin neutralization in mouse  serum, stool, gastric aspirate, suspect foods  Isolation of C. botulinum  in food/faeces, wound, tissue, or gastric  Strict anaerobe, extremely sensitive to oxygen  Clinical signs  Electromyography also diagnostic
  • 27. Prophylaxis and Treatment  Immediate Intensive care once suspected clinically…  Ventilator for respiratory failure  trivalent antitoxin, administer gastric lavage,  metronidazole or penicillin eliminates veg form from GI,  Botulinum antitoxin  Derived from equine source  Trivalent and bivalent antitoxins available through the CDC  Licensed trivalent antitoxin neutralizes type A, B, and E and botulism toxins  Botulism immune globulin  Infant cases of types A and G
  • 28. Therapeutic uses of Botulism Toxin  Involuntary muscles, such as uncontroled eye movements  Cosmetic use Caution required:  70 yrs old underwent botulinum toxin injection to the left inferior rectus muscle, Resulted in loss of the muscle
  • 29. Clostridium difficile-Associated Diarrhea (CDAD)  A group of long term facility patients who were under extended antibiotic treatment all suddenly developed watery diarrhea 10 to 15 times a day, dehydration, fever, loss of appetite, nausea, and abdominal pain/tenderness, and signs of pseudomembranous colitis (damaged tissues,mucus in feces). Upon a quick Gram staining, gram positive spore forming bacilli dominated in samples from all patients.  Reason: Antibiotic overuse  Long term treatment with broad-spectrum antibiotics kills the other bacteria, allowing C. difficile to overgrow, produce enterotoxins that damage intestines, cause diarrhea and colitis
  • 30. Clostridium difficile  Gram positive, anaerobic spore forming, bacilli  Normal resident of colon  In the industrialized world, it is one of the most common diarrheal infections in hospitals and long-term care facilities  Causes antibiotic-associated colitis  relatively non-invasive; treatment with broad-spectrum antibiotics kills the other bacteria, allowing C. difficile to overgrow  Produces enterotoxins that damage intestines  Major cause of diarrhea in hospitals  Increasingly more common in community acquired diarrhea
  • 31. Treatment and prevention  Mild uncomplicated cases respond to fluid and electrolyte replacement and withdrawal of antimicrobials.  Severe infections treated with oral vancomycin or metronidazole and replacement cultures  Increased precautions to prevent spread